| Tekijä(t): | Luntamo, Mari; Rantala, Anne-Maria; Meshnick, Steven R; Yin Bun, Cheung; Kulmala, Teija; Maleta, Kenneth; Ashorn, Per |
| Nimeke: | The Effect of Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on PCR-Diagnosed Malaria at Delivery: A Randomized Controlled Trial |
| Vuosi: | 2012 |
| Lehden nimi: | Plos ONE |
| Vol ja numero: |
|
| Sivunumerot: | 1-8 |
| ISSN: | 1932-6203 |
| Tieteenala: | Oikeuslääketiede ja muut lääketieteet |
| Yksikkö: | Lääketieteen yksikkö |
| Julkaisun tyyppi: | Artikkeli aikakauslehdessä |
| Kieli: | en |
| DOI: | http://dx.doi.org/doi:10.1371/journal.pone.0041123 |
| URN: | URN:NBN:fi:uta-201209041030 |
| URL: | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0041123 |
| Tiivistelmä: | Background
New regimens for intermittent preventive treatment in pregnancy (IPTp) against malaria are needed as the effectiveness of the standard two-dose sulfadoxine-pyrimethamine (SP) regimen is under threat. Previous trials have shown that IPTp with monthly SP benefits HIV-positive primi- and secundigravidae, but there is no conclusive evidence of the possible benefits of this regimen to HIV-negative women, or to a population comprising of both HIV-positive and –negative women of different gravidities. Methods This study analyzed 484 samples collected at delivery as part of a randomized, partially placebo controlled clinical trial, conducted in rural Malawi between 2003 and 2007. The study included pregnant women regardless of their gravidity or HIV-infection status. The participants received SP twice (controls), monthly SP, or monthly SP and two doses of azithromycin (AZI-SP). The main outcome was the prevalence of peripheral Plasmodium falciparum malaria at delivery diagnosed with a real-time polymerase chain reaction (PCR) assay. Findings Overall prevalence of PCR-diagnosed peripheral P. falciparum malaria at delivery was 10.5%. Compared with the controls, participants in the monthly SP group had a risk ratio (95% CI) of 0.33 (0.17 to 0.64, P<0.001) and those in the AZI-SP group 0.23 (0.11 to 0.48, P<0.001) for malaria at delivery. When only HIV-negative participants were analyzed, the corresponding figures were 0.26 (0.12 to 0.57, P<0.001) for women in the monthly SP group, and 0.24 (0.11 to 0.53, P<0.001) for those in the AZI-SP group. Conclusions Our results suggest that increasing the frequency of SP administration during pregnancy improves the efficacy against malaria at delivery among HIV-negative women, as well as a population consisting of both HIV-positive and –negative pregnant women of all gravidities, in a setting of relatively low but holoendemic malaria transmission, frequent use of bed nets and high SP resistance. |
| Lisätiedot: | Public Library of Science open access |